STING1 and cancer: The cGAS-STING pathway, a critical innate immune response mechanism, can be hijacked by tumors to evade immune detection by suppressing the activation of immune signaling, thus enabling cancer cells to escape immune surveillance and promote tumor progression (Fig. 5f).